Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study).

Clerico, M;Schiavetti, I;De Mercanti, SF;Piazza, F;Gned, D;Brescia Morra, V;Lanzillo, R;Ghezzi, A;Bianchi, A;Salemi, G;Realmuto, S;Sola, P;Vitetta, F;Cavalla, P;Paolicelli, D;Trojano, M;SORMANI, MARIA PIA;Durelli, L.

2014-01-01